- Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade
-
Lee J, Ku GY, Lee H, Park HS, Ku JS, Kim JY, Park S, Park BW
- KMID: 2534186
- Cancer Res Treat.
- 2022 Oct;54(4):1074-1080.
- doi: 10.4143/crt.2021.864
Purpose There is a potential risk that lobular carcinoma in situ (LCIS) on preoperative biopsy might be diagnosed as ductal carcinoma in situ (DCIS) or invasive carcinoma in the final pathology.... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinicopathological Features and Prognosis of Lobular Carcinoma In Situ
-
Lee J, Ku GY, Park HS, Lee HM, Ku JS, Kim JY, Park S, Kim SI, Park BW
- KMID: 2517017
- J Breast Dis.
- 2021 Jun;9(1):10-15.
- doi: 10.14449/jbd.2021.9.1.10
Purpose: According to the American Joint Committee on Cancer’s 8th Edition Manual, lobular carcinoma in situ (LCIS) is no longer considered a malignant disease, although it may be a precursor... -
- CITED
-
- Close
- SHARE
-
- Close
